These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 18468872)

  • 21. Trans fatty acids and insulin resistance.
    Risérus U
    Atheroscler Suppl; 2006 May; 7(2):37-9. PubMed ID: 16713388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of trans fatty acid isomers from ruminant sources on risk factors of cardiovascular disease: study design and rationale.
    Gebauer SK; Destaillats F; Mouloungui Z; Candy L; Bezelgues JB; Dionisi F; Baer DJ
    Contemp Clin Trials; 2011 Jul; 32(4):569-76. PubMed ID: 21458598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trans fat involvement in cardiovascular disease.
    Ganguly R; Pierce GN
    Mol Nutr Food Res; 2012 Jul; 56(7):1090-6. PubMed ID: 22760981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fatty acid composition including trans-fatty acids in edible oils and fats: probable intake in Indian population.
    Dixit S; Das M
    J Food Sci; 2012 Oct; 77(10):T188-99. PubMed ID: 22950538
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trans fatty acids (TFA): analysis, occurrence, intake and clinical relevance.
    Steinhart H; Rickert R; Winkler K
    Eur J Med Res; 2003 Aug; 8(8):358-62. PubMed ID: 12915330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trans fatty acids and blood lipids.
    Ascherio A
    Atheroscler Suppl; 2006 May; 7(2):25-7. PubMed ID: 16713394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trans fatty acids: are its cardiovascular risks fully appreciated?
    Nestel P
    Clin Ther; 2014 Mar; 36(3):315-21. PubMed ID: 24636816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A cross-sectional study on trans-fatty acids and risk markers of CHD among middle-aged men representing a broad range of BMI.
    Nielsen BM; Nielsen MM; Jakobsen MU; Nielsen CJ; Holst C; Larsen TM; Bendsen NT; Bysted A; Leth T; Hougaard DM; Skogstrand K; Astrup A; Sørensen TI; Jess T
    Br J Nutr; 2011 Oct; 106(8):1245-52. PubMed ID: 21736833
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intake of ruminant trans fatty acids and risk of coronary heart disease-an overview.
    Jakobsen MU; Bysted A; Andersen NL; Heitmann BL; Hartkopp HB; Leth T; Overvad K; Dyerberg J
    Atheroscler Suppl; 2006 May; 7(2):9-11. PubMed ID: 16713389
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Dietary trans-fatty acids and metabolic syndrome].
    Kochan Z; Karbowska J; Babicz-Zielińska E
    Postepy Hig Med Dosw (Online); 2010 Dec; 64():650-8. PubMed ID: 21228440
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trans fatty acids and coronary heart disease.
    Zaloga GP; Harvey KA; Stillwell W; Siddiqui R
    Nutr Clin Pract; 2006 Oct; 21(5):505-12. PubMed ID: 16998148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contents of trans-fatty acids in human substernal adipose tissue and plasma lipids: relation to angiographically documented coronary heart disease.
    Fritsche J; Steinhart H; Kardalinos V; Klose G
    Eur J Med Res; 1998 Aug; 3(8):401-6. PubMed ID: 9707524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High dietary consumption of trans fatty acids decreases brain docosahexaenoic acid but does not alter amyloid-beta and tau pathologies in the 3xTg-AD model of Alzheimer's disease.
    Phivilay A; Julien C; Tremblay C; Berthiaume L; Julien P; Giguère Y; Calon F
    Neuroscience; 2009 Mar; 159(1):296-307. PubMed ID: 19135506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Learning from international policies on trans fatty acids to reduce cardiovascular disease in low- and middle-income countries, using Mexico as a case study.
    Pérez-Ferrer C; Lock K; Rivera JA
    Health Policy Plan; 2010 Jan; 25(1):39-49. PubMed ID: 19741052
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dietary intake of trans fatty acids as a cardiovascular risk factor in a population of Italian teenagers.
    Sofi F; Rapini D; Innocenti G; Abbate R; Gensini GF; Casini A
    Cardiol Young; 2009 Dec; 19(6):589-93. PubMed ID: 19825251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trans fatty acids and weight gain.
    Thompson AK; Minihane AM; Williams CM
    Int J Obes (Lond); 2011 Mar; 35(3):315-24. PubMed ID: 20644558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of quality of dietary fat on serum cholesterol and coronary heart disease: focus on plant sterols and other non-glyceride components.
    Ghafoorunissa
    Natl Med J India; 2009; 22(3):126-32. PubMed ID: 19764688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trans-fatty acids and cancer: the evidence reviewed.
    Thompson AK; Shaw DI; Minihane AM; Williams CM
    Nutr Res Rev; 2008 Dec; 21(2):174-88. PubMed ID: 19087370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Consumption of Oxidized and Partially Hydrogenated Oils Differentially Induces Trans-Fatty Acids Incorporation in Rats' Heart and Dyslipidemia.
    Dhibi M; Mnari A; Brahmi F; Houas Z; Chargui I; Kharroubi W; Hammami M
    J Am Coll Nutr; 2016; 35(2):125-35. PubMed ID: 25794039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The scientific basis for TFA regulations-is it sufficient? Comments from the USA.
    Willett WC
    Atheroscler Suppl; 2006 May; 7(2):69-71. PubMed ID: 16716766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.